| Gene symbol | MSLN | Synonyms | MPF, SMRP | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mesothelin | ||||
| GTO ID | GTC3030 |
| Trial ID | NCT05373147 |
| Disease | Solid Tumor |
| Altered gene | MSLN |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MSLN CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors |
| Year | 2022 |
| Country | China |
| Company sponsor | Shanghai Mengchao Cancer Hospital |
| Other ID(s) | BZDS1901 |
| Cohort 1 | |||||||||||
|
|||||||||||